CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
Titel:
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
Auteur:
Zhou, Xinna Qiao, Guoliang Wang, Xiaoli Song, Qingkun Morse, Michael A. Hobeika, Amy Gwin, William R. Ren, Jun Lyerly, H. Kim